APA

Beumer J. H., Eiseman J. L., Parise R. A., Joseph E., Covey J. M. & Egorin M. J. (20080828). Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Beumer Jan H, Eiseman Julie L, Parise Robert A, Joseph Erin, Covey Joseph M and Egorin Merrill J. 20080828. Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Beumer J. H., Eiseman J. L., Parise R. A., Joseph E., Covey J. M. and Egorin M. J. (20080828). Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Beumer Jan H, Eiseman Julie L, Parise Robert A, Joseph Erin, Covey Joseph M and Egorin Merrill J. Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20080828.